$35.75
0[0.00%]
Last update: 4:20PM Get Real Time Here
Baxter Intl
(NYSE:BAX)Latest News for Baxter Intl Stock (NYSE:BAX)
Baxter Intl Stock (NYSE: BAX)
Categories: All
Thursday, May 02, 2024
- Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?Vandana Singh - 6 days ago
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - May 2, 2024, 1:35PM
- Looking At Baxter Intl's Recent Unusual Options ActivityBenzinga Insights - May 2, 2024, 1:31PM
- Baxter International shares are trading lower following soft Q2 EPS guidance.Benzinga Newsdesk - May 2, 2024, 10:25AM
- Baxter International Sees Q2 2024 Adj. EPS $0.65-$0.67 Vs $0.68 Est.Benzinga Newsdesk - May 2, 2024, 7:20AM
- Baxter International Sees FY24 Adj. EPS $2.88-$2.98 Vs $2.90 Est.Benzinga Newsdesk - May 2, 2024, 7:20AM
- Baxter Intl Q1 2024 Adj EPS $0.65 Beats $0.61 Estimate, Sales $3.590B Beat $3.553B EstimateBenzinga Newsdesk - May 2, 2024, 7:16AM
Thursday, April 11, 2024
Wednesday, April 03, 2024
Monday, April 01, 2024
- Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump SystemVandana Singh - Apr 1, 2024, 12:38PM
- Baxter Announces US FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion TherapyBenzinga Newsdesk - Apr 1, 2024, 7:16AM
Wednesday, March 20, 2024
Tuesday, March 05, 2024
Wednesday, February 21, 2024
Monday, February 12, 2024
Friday, February 09, 2024
Thursday, February 08, 2024
- Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions UnitVandana Singh - Feb 8, 2024, 12:51PM
- Baxter Forecasts FY24 Adjusted EPS Of $2.85-$2.95 Versus Consensus Of $2.94, With Sales Growth Of Approximately 2% On Both A Reported And Constant Currency BasisBenzinga Newsdesk - Feb 8, 2024, 7:20AM
- Baxter Forecasts Q1 FY24 Adjusted EPS Of $0.59-$0.62 Versus Consensus Of $0.63, With Sales Growth Of Approximately 1% On A Reported Basis And 1%-2% On A Constant Currency BasisBenzinga Newsdesk - Feb 8, 2024, 7:19AM
- Baxter Intl Q4 Adjusted EPS $0.88 Beats $0.86 Estimate, Sales $3.88B Beat $3.80B EstimateBenzinga Newsdesk - Feb 8, 2024, 7:16AM
- Earnings Scheduled For February 8, 2024Benzinga Insights - Feb 8, 2024, 4:43AM
Tuesday, December 12, 2023
Monday, December 04, 2023
Monday, November 06, 2023
Thursday, November 02, 2023
- Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?Vandana Singh - Nov 2, 2023, 2:50PM
- Baxter International shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 and FY23 guidance.Benzinga Newsdesk - Nov 2, 2023, 11:59AM
- Baxter Expects Q4 FY23 Sales Growth From Continuing Operations Of 1% To 2% On A Reported Basis And Approximately 1% On A Constant Currency BasisBenzinga Newsdesk - Nov 2, 2023, 7:24AM
- Baxter Expects Q4 FY23 Adjusted EPS From Continuing Operations Of $0.85-$0.88 Versus Consensus Of $0.84Benzinga Newsdesk - Nov 2, 2023, 7:23AM
- Baxter Expects Sales Growth From Continuing Operations Of 1%-2% On A Reported Basis And Approximately 2% On A Constant Currency BasisBenzinga Newsdesk - Nov 2, 2023, 7:22AM
- Baxter Expects FY23 Adjusted EPS From Continuing Operations Of $2.57-$2.60 Versus Consensus Of $2.59Benzinga Newsdesk - Nov 2, 2023, 7:21AM
- Baxter Intl Q3 Adjusted EPS $0.82 Beats $0.68 Estimate, Sales $3.71B Beat $3.69B EstimateBenzinga Newsdesk - Nov 2, 2023, 7:19AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Tuesday, October 31, 2023
Wednesday, October 11, 2023
- Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Oct 11, 2023, 1:13PM
- Shares of dialysis providers and kidney care stocks are trading lower after Novo Nordisk stopped its semaglutide kidney outcomes trial early based on early signs of efficacy.Bill Haddad - Oct 11, 2023, 11:03AM
- What's Going On With Kidney Dialysis Provider Stocks Today?Vandana Singh - Oct 11, 2023, 9:52AM
- Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionLisa Levin - Oct 11, 2023, 6:00AM
Tuesday, October 10, 2023
Tuesday, October 03, 2023
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Oct 3, 2023, 2:37PM
- Baxter Has Appointed Joel Grade As Executive Vice President & CFO, Effective October 18. Brian Stevens, Who Has Served As The Interim CFO Since May 31, Will Move To His Prior Role As SVP, Chief Accounting Officer, ControllerBenzinga Newsdesk - Oct 3, 2023, 9:07AM